These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 32583963

  • 1. Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia.
    de Jesús GR, Lacerda MI, Rodrigues BC, Dos Santos FC, do Nascimento AP, Cristóvão Porto L, de Jesús NR, Levy RA, Klumb EM.
    Arthritis Care Res (Hoboken); 2021 May; 73(5):717-721. PubMed ID: 32583963
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy.
    Hirashima C, Ogoyama M, Abe M, Shiraishi S, Sugase T, Niki T, Matsubara S, Ohkuchi A.
    CEN Case Rep; 2019 May; 8(2):95-100. PubMed ID: 30565047
    [Abstract] [Full Text] [Related]

  • 3. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
    Leaños-Miranda A, Campos-Galicia I, Berumen-Lechuga MG, Molina-Pérez CJ, García-Paleta Y, Isordia-Salas I, Ramírez-Valenzuela KL.
    J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
    [Abstract] [Full Text] [Related]

  • 4. The role of angiogenic biomarkers and uterine artery Doppler in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome.
    Rodríguez-Almaraz ME, Herraiz I, Gómez-Arriaga PI, Vallejo P, Gonzalo-Gil E, Usategui A, López-Jiménez EA, Galindo A, Galindo M.
    Pregnancy Hypertens; 2018 Jan; 11():99-104. PubMed ID: 29523283
    [Abstract] [Full Text] [Related]

  • 5. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.
    Qazi U, Lam C, Karumanchi SA, Petri M.
    J Rheumatol; 2008 Apr; 35(4):631-4. PubMed ID: 18278839
    [Abstract] [Full Text] [Related]

  • 6. Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus.
    Mayer-Pickel K, Stern C, Eberhard K, Lang U, Obermayer-Pietsch B, Cervar-Zivkovic M.
    J Reprod Immunol; 2018 Jun; 127():19-23. PubMed ID: 29689494
    [Abstract] [Full Text] [Related]

  • 7. Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.
    Andrade D, Kim M, Blanco LP, Karumanchi SA, Koo GC, Redecha P, Kirou K, Alvarez AM, Mulla MJ, Crow MK, Abrahams VM, Kaplan MJ, Salmon JE.
    Arthritis Rheumatol; 2015 Apr; 67(4):977-87. PubMed ID: 25603823
    [Abstract] [Full Text] [Related]

  • 8. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.
    Matin M, Mörgelin M, Stetefeld J, Schermer B, Brinkkoetter PT, Benzing T, Koch M, Hagmann H.
    Hypertension; 2020 Oct; 76(4):1176-1184. PubMed ID: 32623922
    [Abstract] [Full Text] [Related]

  • 9. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE.
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [Abstract] [Full Text] [Related]

  • 10. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
    Nguyen TH, Bui TC, Vo TM, Tran QM, Luu LT, Nguyen TD.
    Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L, Tahitu SIM, Danser AHJ, van den Meiracker AH, Visser W.
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [Abstract] [Full Text] [Related]

  • 12. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY.
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia.
    Lecarpentier É, Vieillefosse S, Haddad B, Fournier T, Leguy MC, Guibourdenche J, Tsatsaris V.
    Ann Biol Clin (Paris); 2016 Jun 01; 74(3):259-67. PubMed ID: 27237799
    [Abstract] [Full Text] [Related]

  • 20. Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia: a pilot study.
    Raio L, Bersinger NA, Malek A, Schneider H, Messerli FH, Hürter H, Rimoldi SF, Baumann MU.
    J Hypertens; 2019 May 01; 37(5):1012-1017. PubMed ID: 30882594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.